Zaslav David 4
Research Summary
AI-generated summary
Televisa (TV) Director David Zaslav Exercises Options, Sells Shares
What Happened
David Zaslav, a director of Grupo Televisa, exercised in‑the‑money derivatives on April 30, 2026. The filing shows 55,500 shares reported as acquired at $0.46 each (total $25,530) and 55,500 shares reported as disposed at $0.00 (total $0). Separately, 8,900 shares were sold in an open‑market or private sale at $2.88 each for proceeds of $25,632. The zero‑price disposition and related footnotes indicate shares were surrendered/withheld (or sold by the administering trust) to cover the exercise price and related amounts.
Key Details
- Transaction date: 2026-04-30. Purchase/exercise price reported $0.46 per share (55,500 shares; $25,530). Open‑market sale: 8,900 shares at $2.88 ($25,632). A 55,500 share disposition at $0.00 is also reported (likely withholding/surrender).
- Shares owned after transaction: Not specified in the filing.
- Notable footnotes:
- F1: These are Global Depositary Shares (GDSs) that represent interests in Mexican CPOs; each GDS maps to multiple Mexican share classes.
- F2: USD amounts reflect conversion from Mexican pesos at 17.3853 MXN/USD (as of Apr 24, 2026).
- F3/F5: The trust that administers the Stock Purchase Plan for Directors sold a portion of GDSs on behalf of the reporting person (and similarly situated persons) to pay the Ps.8.00 per GDS price and related obligations; proceeds/prices are averaged across those sales.
- Filing timeliness: Report filed 2026-05-04 for a 2026-04-30 transaction — filed within the standard 2 business‑day window.
Context
This was primarily an exercise of derivatives with shares withheld/sold to cover the exercise cost and related obligations (a common "cashless" or net‑settlement-style outcome). The separate sale of 8,900 GDSs was an open‑market/private sale by the trust reporting proceeds of $25,632. Such exercises plus immediate withholding or sale to cover costs are routine and do not by themselves signal insider sentiment.